Log in to save to my catalogue

Selective Hydrogenation of Benzylidenethiazolidinedione Exocyclic Alkene with Anti-poisoning Nitroge...

Selective Hydrogenation of Benzylidenethiazolidinedione Exocyclic Alkene with Anti-poisoning Nitroge...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3153612912

Selective Hydrogenation of Benzylidenethiazolidinedione Exocyclic Alkene with Anti-poisoning Nitrogen-Doped Carbon Supported Palladium Catalysts

About this item

Full title

Selective Hydrogenation of Benzylidenethiazolidinedione Exocyclic Alkene with Anti-poisoning Nitrogen-Doped Carbon Supported Palladium Catalysts

Publisher

New York: Springer US

Journal title

Catalysis letters, 2024-02, Vol.154 (2), p.387-396

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

Pioglitazone has been developed as an effective insulin-sensitizing agent for the treatment of type II diabetes mellitus. Selective hydrogenation of the benzylidenethiazolidinedione exocyclic alkene is a committed step in the industrial manufacturing of pioglitazone. However, the strong coordination between metallic sites of commercial hydrogenatio...

Alternative Titles

Full title

Selective Hydrogenation of Benzylidenethiazolidinedione Exocyclic Alkene with Anti-poisoning Nitrogen-Doped Carbon Supported Palladium Catalysts

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_3153612912

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3153612912

Other Identifiers

ISSN

1011-372X

E-ISSN

1572-879X

DOI

10.1007/s10562-023-04340-z

How to access this item